All News

At a session of the CHEST Annual Meeting 2021, specialists reviewed the need for a thorough diagnosis to tell whether a patient's symptoms are caused by asthma or another pulmonary condition.

The low-dose tablet will help pediatric patients weighing between 14 kg and 25 kg who are virologically suppressed or new to antiretroviral therapy.

Researchers explored how the gut-brain axis may affect pediatric migraineurs.

Camillo Ricordi, MD, FNAI, outlines what needs to happen next in the islet transplantation field.

Merck has submitted data on its COVID-19 pill to the FDA after a successful trial; air, land, and ferry travelers will be allowed into the United States in November if they show proof of vaccination; 13 of 33 certified community behavioral health clinics in Michigan will be reimbursed by Medicaid.

Researchers at the CHEST Annual Meeting 2021 addressed the evolution of COVID-19 variants, how these emerging strains impact vaccines, and preventive recommendations for at-risk populations.

There are several reasons as to why precision therapeutics have not taken off for chronic obstructive pulmonary disease (COPD) in the same way that they have for other diseases, said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.

Panelists of a session at CHEST 2021 discuss the latest research regarding efficacy and safety of therapies in the management of asthma, including biologics, corticosteroids, and more.

Evan L. Stepp, MD, FCCP, CPE, a pulmonologist at National Jewish Health, director of the Highlands Ranch Clinic, and an assistant professor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, discussed the recent FDA decision to authorize an e-cigarette intended to help current smokers quit combustible cigarettes.

Investigators in a retrospective study of patients with diffuse large B-cell lymphoma (DLBCL) sought to understand the correlation between muscle loss and immunochemotherapy.

With sleep apnea and abnormal sleep patterns typifying Prader-Willi syndrome, researchers from Sweden and Denmark theorized that treatment with growth hormone may improve both for individuals affected by the rare neurodevelopmental disease.

Older individuals with a weekday bedtime later than midnight were associated with a greater risk of myocardial infarction. No elevated risks were observed according to weekend bedtimes.

A recent study compared intelligence quotient test scores between adult patients with spinal muscular atrophy (SMA) and healthy adults.

Most patients with Fabry disease reported decreased physical and mental health-related quality of life (HRQOL) over 13 years of follow-up.

New retrospective research found that basal and squamous cell cancers increased by 30% over 15 years.

Kirollos Hanna, PharmD, manager of Oncology Pharmacy at the University of Minnesota Medical Center, explains the process behind how his practice chooses which biosimilars to stock and provide for patients.

More than 1 in 3 patients with Parkinson disease were found to experience minor hallucinations, which were linked with worse quality of life and poor sleep outcomes.

Researchers conducted a randomized clinical trial to test the efficacy of a hybrid closed-loop (HCL) system among pediatric patients with type 1 diabetes (T1D).

Some alcohol, but not more than 1 drink per day, was linked to a 55% lower risk of type 2 diabetes in women with a history of gestational diabetes.

A case study of a patient with Niemann-Pick disease who developed hepatocellular carcinoma highlights the importance of screening in this population.

A patient with pulmonary arterial hypertension (PAH) who received a modified Potts shunt exhibited improved quality of life and exercise capacity after 1 year.

Analyses of genome-wide association studies revealed the potential role metabolite levels play in migraine pathophysiology.

There was statistically significant and clinically meaningful overall survival benefit vs sorafenib as a first-line treatment for patients with unresectable hepatocellular carcinoma (HCC) in top-line results from a phase 3 trial.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An independent FDA advisory panel endorses Moderna boosters for select groups; circuit court lets Texas abortion law stand, paving the way for appeals; Robert Califf, MD, is reportedly being eyed to head the FDA again.

Pediatric populations, young adults, and parents all identified differing goals and preferences of treatment for psoriasis, with the most important treatment goals overall cited as lesion prevention and reduction.

New data presented at IDWeek 2021 show lack of pre-exposure prophylaxis (PrEP) uptake among groups at high risk of HIV infection.

University of Birmingham researchers point to potential benefits via reduced unbound active androgens, low levels of which increase the body’s response to insulin and decrease the likelihood of hirsutism in women with polycystic ovary syndrome (PCOS) at risk of developing type 2 diabetes (T2D).